David Hickey - 15 Aug 2022 Form 4 Insider Report for BECTON DICKINSON & CO (BDX)

Reporting relationship: EVP & President, Life Sciences
Issuer ticker: BDX
Reported as of: 15 Aug 2022
Net transaction value: -$125,875
SEC form: 4
Accepted by SEC: 17 Aug 2022, 07:21:32 UTC
Prior SEC filing: 10 May 2022
Next SEC filing: 29 Nov 2022
Source filing: View source filing
Reporting owner signature: Donna Kalazdy, by power of attorney for David Hickey

Key filing fact

David Hickey filed Form 4 for BECTON DICKINSON & CO (BDX) on 17 Aug 2022.

Key facts

This page summarizes David Hickey's Form 4 filing for BECTON DICKINSON & CO (BDX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Aug 2022, 07:21.

Change

Previous filing in this sequence was filed on 10 May 2022.
Current net transaction value: -$125,875.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BDX transaction

Common Stock

Sale

Transaction value: $125,875
Shares: -475
Change %: -12%
Price: $265.00
Shares after: 3,331
Date: 15 Aug 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Direct holdings reflect adjustments made in connection with the spin-off of Embecta Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person. This transaction was made pursuant to a 10b5-1 plan entered into on March 9, 2022.